These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Testing the radiochemical purity of technetium Tc 99m-labeled radiopharmaceuticals. Hung JC; Budde PA; Wilson ME Am J Health Syst Pharm; 1995 Feb; 52(3):310-3. PubMed ID: 7749960 [No Abstract] [Full Text] [Related]
4. Panel discussion: proposed changes in the USP--microbiological aspects. I. Proposed changes in the USP sterility test. Clapp FL Bull Parenter Drug Assoc; 1969; 23(6):252-4. PubMed ID: 4901566 [No Abstract] [Full Text] [Related]
5. Compounding facilities assessment and planning: A focus on USP <797> and USP <800>. Clark JS; Tharp JC; Patel D; Desmarais A Am J Health Syst Pharm; 2020 Oct; 77(22):1910-1913. PubMed ID: 32839816 [No Abstract] [Full Text] [Related]
6. The development of USP botanical dietary supplement monographs, 1995-2005. Schiff PL; Srinivasan VS; Giancaspro GI; Roll DB; Salguero J; Sharaf MH J Nat Prod; 2006 Mar; 69(3):464-72. PubMed ID: 16562859 [TBL] [Abstract][Full Text] [Related]
8. USP issues standards for unit dose repackaging. Am J Health Syst Pharm; 2002 Jun; 59(11):1032, 1034. PubMed ID: 12063888 [No Abstract] [Full Text] [Related]
9. While shopping for an herbal supplement, I noticed that some labels say the supplement is USP verified. What does that mean? Mayo Clin Health Lett; 2004 Oct; 22(10):8. PubMed ID: 15609437 [No Abstract] [Full Text] [Related]
10. Panel discussion: Proposed changes in the USP--Microbiological aspects. II. Biological indicators. Artandi C Bull Parenter Drug Assoc; 1969; 23(6):254-7. PubMed ID: 4901567 [No Abstract] [Full Text] [Related]
11. Results of advisory panel on USP Chapter 797. Jt Comm Perspect; 2004 Oct; 24(10):12-4. PubMed ID: 15560422 [No Abstract] [Full Text] [Related]
12. US Pharmacopeia Council of Experts 2005-2010: work plans, new revision approaches, and other enhancements. Williams RL AAPS J; 2006; 8(4):E661-4. PubMed ID: 17285738 [TBL] [Abstract][Full Text] [Related]
13. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations. Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622 [No Abstract] [Full Text] [Related]
14. Equivalence studies for complex active ingredients and dosage forms. Bhattycharyya L; Dabbah R; Hauck W; Sheinin E; Yeoman L; Williams R AAPS J; 2005 Nov; 7(4):E786-812. PubMed ID: 16594632 [TBL] [Abstract][Full Text] [Related]
15. USP and PET radiopharmaceuticals: 1997 FDAMA puts standard-setting body at center of regulatory process. Hung JC; Callahan RJ J Nucl Med; 2004 Jan; 45(1):13N-14N, 16N. PubMed ID: 14734661 [No Abstract] [Full Text] [Related]
17. USP Veterinary Pharmaceutical Information Monographs--Anti-inflammatories. Veterinary Medicine Expert Committee on Drug Information, United States Pharmacopeia J Vet Pharmacol Ther; 2004 Jun; 27 Suppl 1():1-110. PubMed ID: 15175088 [No Abstract] [Full Text] [Related]
19. Some aspects of the USP pyrogen test. Lamey RT; Weary ME; Murphy BF Bull Parenter Drug Assoc; 1969; 23(6):245-51. PubMed ID: 5355887 [No Abstract] [Full Text] [Related]
20. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115 [No Abstract] [Full Text] [Related] [Next] [New Search]